Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | TLR2 | O60603 | 3/20 | 0.47 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.45 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30693894 | 0.97 | KMT2A (0.51) | KMT2ATLR2MDM2TPSAB1 | |
| SCHEMBL29875729 | 0.91 | KMT2A (0.53) | KMT2ATLR2MDM2 | |
| SCHEMBL29401239 | 0.91 | KMT2A (0.53) | KMT2ATLR2MDM2 | |
| SCHEMBL26093325 | 0.91 | KMT2A (0.53) | KMT2ATLR2MDM2 | |
| SCHEMBL120403 | 0.91 | KMT2A (0.53) | KMT2ATLR2MDM2 | |
| SCHEMBL29047056 | 0.91 | KMT2A (0.50) | KMT2ATLR2MDM2TPSAB1 | |
| SCHEMBL15521165 | 0.91 | KMT2A (0.53) | KMT2ATLR2MDM2 | |
| SCHEMBL29514568 | 0.91 | KMT2A (0.53) | KMT2ATLR2MDM2 | |
| SCHEMBL18237098 | 0.91 | KMT2A (0.53) | KMT2ATLR2MDM2 | |
| SCHEMBL31119413 | 0.90 | KMT2A (0.50) | KMT2ATLR2TPSAB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382344-A1 | Soluble GLP1/GIP/NPY2 Receptor Triple Agonists | BOEHRINGER INGELHEIM INT GMH (DE) | 2025-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250382344-A1 | Soluble GLP1/GIP/NPY2 Receptor Triple Agonists | GLP1R, GIPR, NPY1R | KMT2A 2259/4885TLR2 1048/4885MDM2 4137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.